Elicio Therapeutics, Inc.

Historical 13F Holders

Symbol: ELTX
CUSIP: 28657F103
All holders as of: Q2 2026
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

13D/G Filers

Each filer's latest filing for 28657F103 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Yekaterina Chudnovsky 13D/A	48.1%	9,657,539	13D/A	3/7/2025 Event 3/5/2025
Yekaterina Chudnovsky	48.1%	9,657,539
GKCC, LLC	48.0%	9,648,914
GKCC, LLC 13D/A	48.0%	9,764,864	13D/A	6/4/2025 Event 6/3/2025
GKCC, LLC	48.0%	9,752,139
Yekaterina Chudnovsky	48.0%	9,764,864
Moti Investments LLC 13G	6.1%	1,408,892	13G	7/16/2026 Event 7/1/2026
Knoll Capital Management, LLC 13G/A	5.3%	1,211,957	13G/A	7/8/2026 Event 7/1/2026
Knoll Capital Management, LLC	5.3%	1,211,957
Fred Knoll	5.3%	1,211,957
Gakasa Holdings, LLC	5.3%	1,211,957
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Actyus Private Equity SGIIC, S.A. 13G/A	1.6%	268,564	13G/A	10/7/2025 Event 9/30/2025

13F Holders by Quarter

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	27	1.81 M	$3.30M	$0
2026 Q2	55	3.92 M	$15.3M	$7.38M
2026 Q1	49	2.64 M	$28.2M	$5.26M
2025 Q4	39	2.08 M	$16.6M	$2.79M
2025 Q3	31	1.91 M	$20.9M	$1.54M
2025 Q2	24	1.45 M	$11.2M	$926k
2025 Q1	25	1.59 M	$9.80M	$0
2024 Q4	18	454 k	$2.25M	$0
2024 Q3	19	491 k	$2.48M	$0
2024 Q2	21	649 k	$2.68M	$0
2024 Q1	19	407 k	$3.08M	$0
2023 Q4	19	333 k	$2.78M	$0
2023 Q3	19	331 k	$2.80M	$0
2023 Q2	16	286 k	$2.71M	$0